For small drugmakers playing fast and loose with quality, trouble is on way

[ad_1] The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), will do the checks to review the compliance status of MSME drug firms’ good manufacturing practices (GMP), the people added. “Right now, DCGI is still getting applications as the deadline is open,” the first official said. “Only after…

Read More

Imports weaken Indian pharma – The Hindu

[ad_1] New medicines are generally under patent protection, preventing Indian companies from producing affordable generics/biosimilars. | Photo Credit: Getty Images/iStockphoto Ensuring the affordability of pharmaceuticals is essential for controlling healthcare costs, especially in India, where out-of-pocket health expenditures accounted for nearly 47.1% of the total health expenditure in 2021. While the Drugs Price Control Order,…

Read More
Back To Top